and apolipoprotein B = 1P3 g/l. These var- iability in classification into high and low risk subjects when using the total cholesterol concentration alone compared with compound risk indices. Smoking was more prevalent in the high risk groups defined by the compound indices than by total cholesterol. These findings call for caution when total cholesterol is used to estimate cardiovascular risk in epidemiological studies, and even more so at individual counselling in occupational or primary health care settings. The presence of fewer women in the high risk groups in our study agrees with a lower cardiovascular risk in women than in men. As the Berg, Hostmark group.bmj.com on July 6, 2017 -Published by http://jech.bmj.com/ Downloaded from emphasis in this study was on comparing risk evaluation by total cholesterol alone and the other indices, being a woman signified only a lower probability of being at risk.
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It is emphasised that there are, as yet, no prospective studies supporting the hypothesis that the atherogenic index provides higher predictive power than the total cholesterol concentration alone.
Lipid lowering medication has been advocated when finding high total cholesterol concentrations. The results obtained in our study indicate that great caution is needed before such action is taken. Our observation of widely varying numbers of persons allocated to the high risk groups by the three indices, favours using a broader blood lipid base for treatment decisions. However, other risk measures, such as family history, blood pressure, physical activity, diet, and smoking habits should also be considered.
Reliable data on diet are hard to obtain through questionnaire.2"29 The diet indicators we used, which were found to be significant in an earlier study,'9 failed to discriminate between people at low and high risk.
In conclusion, although the serum total cholesterol concentration is shown to be associated with an increased cardiovascular mortality in epidemiological studies, our results favour measuring both total and HDL cholesterol, as well as apolipoproteins, in cardiovascular risk evaluation. One particular concern when using the compound indices, however, is the accuracy of laboratory procedures used for apolipoprotein measurements.
It is tempting to speculate that some of the lack of success, evaluated as reduced mortality associated with reduction of serum total cholesterol,3 may be attributed to the low predictive value of serum total cholesterol, which is accounted for by the multifactorial nature of cardiovascular diseases.
